Author(s)

Sawsan A. Nasr¹, Omer O. A. Ahmed-Farid¹, El-Shaymaa A. Zein-El-Abedeen²

¹Physiology Department, National Organization for Drug Control and Research, Giza, Egypt.
²Biochemistry Department, National Organization for Drug Control and Research, Giza, Egypt.

The present study is performed to investigate the effect of two different glucosamine containing drugs: Drug 1 and Drug 2 (D1 and D2) against CCl₄ induced brain damage in male albino rats. Liverin (AM) was employed in the current study as an antioxidant reference drug. CCl₄ administration caused a significant elevation in the levels of MDA and NO of brain tissue, in association with a significant decrease in the antioxidant defense system (GSH, SOD and GPX) that indicated the induction of oxidative stress in brain tissue. CCl₄ administration induced brain injury as manifested by the obtained changes in neurotransmitter parameter (norepinephrine (NE), Dopamine (DA), Serotonin (5-HT), and Acetylcholinesterase AChE). The tested nutraceuticals and the antioxidant drug displayed a significant improvement against the undue effect of CCl₄ via decreasing the brain tissue content of MDA, NO with the elevation of GSH content. Also, the significant increase in SOD and GPX enzymatic activity was obtained when compared to CCL₄ group. In addition AM, D1, and D2 have an ameliorative effect on neurotransmitter parameter NE, DA, 5HT, and AChE. Results of this study suggest that both antioxidant drugs and tested nutraceuticals palliate the brain injuries through anti-oxidative effect, with the elimination of the deleterious effect of toxic metabolites of CCl₄ on brain tissue.

CCL4, Glucosamine, Antioxidant and Neurotransmitter

Nasr, S. , Ahmed-Farid, O. and Zein-El-Abedeen, E. (2020) Beneficial Effects of Some Nutraceuticals Containing Glucosamine and Antioxidant against CCL4 Induced Brain Injury in Rats. Open Journal of Applied Sciences, 10, 1-14. doi: 10.4236/ojapps.2020.101001.